Why You Should Not Use Ivermectin to Treat or Prevent COVID-19
Using the Drug ivermectin to treat COVID-19 can be dangerous and even lethal. The FDA has not approved the drug for that purpose.
Using the Drug ivermectin to treat COVID-19 can be dangerous and even lethal. The FDA has not approved the drug for that purpose.
Learn how smoking cigarettes can damage important parts of your eyes necessary for maintaining clear eyesight and vision.
This case report illustrates the need for real-time integration of proteogenomic data from laser microdissected tumor specimens and dynamic biopsy testing
Tyrosine kinase inhibitors and immune checkpoint inhibitors (ICIs), each requiring testing for precision biomarkers, have recently been approved in the adjuvant setting. We assessed the…
Comprehensive genomic profiling (CGP) uses next-generation sequencing methods to detect specific molecular abnormalities in a patient’s tumor. CGP can disclose biomarkers at nucleotide-level resolution and…
PURPOSE Clinical trials of novel and targeted agents increasingly require biomarkers for eligibility. Precision oncology continues to evolve, but challenges hamper broad use of molecular…
PURPOSE Many patients with actionable driver oncogenes (ADOs) are never identified and thus never receive targeted treatment. This study evaluated the economic impact and the…
Abstract. The Veterans Health Administration is the largest integrated provider of cancer services in the nation, with approximately 50,000 new cancer cases dia
Quantification of the precision oncology landscape and clinical actionability in patients with cancer shows an increase in the fraction of genomic biomarkers of response to…
University Hospitals, MetroHealth and Southwest General all reported operating losses in 2023; net income up at Cleveland Clinic
AbstractUsing 48,627 samples from the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), we present a pan-cancer landscape of driver alterations and their clinical actionability…